BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

493 related articles for article (PubMed ID: 12851486)

  • 1. Multiple roles of the PI3K/PKB (Akt) pathway in cell cycle progression.
    Liang J; Slingerland JM
    Cell Cycle; 2003; 2(4):339-45. PubMed ID: 12851486
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD28 costimulation mediates down-regulation of p27kip1 and cell cycle progression by activation of the PI3K/PKB signaling pathway in primary human T cells.
    Appleman LJ; van Puijenbroek AA; Shu KM; Nadler LM; Boussiotis VA
    J Immunol; 2002 Mar; 168(6):2729-36. PubMed ID: 11884439
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Control of cell cycle exit and entry by protein kinase B-regulated forkhead transcription factors.
    Kops GJ; Medema RH; Glassford J; Essers MA; Dijkers PF; Coffer PJ; Lam EW; Burgering BM
    Mol Cell Biol; 2002 Apr; 22(7):2025-36. PubMed ID: 11884591
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The phosphoinositide 3-kinase/Akt pathway regulates cell cycle progression of HL60 human leukemia cells through cytoplasmic relocalization of the cyclin-dependent kinase inhibitor p27(Kip1) and control of cyclin D1 expression.
    Cappellini A; Tabellini G; Zweyer M; Bortul R; Tazzari PL; Billi AM; FalĂ  F; Cocco L; Martelli AM
    Leukemia; 2003 Nov; 17(11):2157-67. PubMed ID: 12931221
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell cycle inhibition by FoxO forkhead transcription factors involves downregulation of cyclin D.
    Schmidt M; Fernandez de Mattos S; van der Horst A; Klompmaker R; Kops GJ; Lam EW; Burgering BM; Medema RH
    Mol Cell Biol; 2002 Nov; 22(22):7842-52. PubMed ID: 12391153
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ErbB2/neu kinase modulates cellular p27(Kip1) and cyclin D1 through multiple signaling pathways.
    Lenferink AE; Busse D; Flanagan WM; Yakes FM; Arteaga CL
    Cancer Res; 2001 Sep; 61(17):6583-91. PubMed ID: 11522658
    [TBL] [Abstract][Full Text] [Related]  

  • 7. G1 cell cycle progression and the expression of G1 cyclins are regulated by PI3K/AKT/mTOR/p70S6K1 signaling in human ovarian cancer cells.
    Gao N; Flynn DC; Zhang Z; Zhong XS; Walker V; Liu KJ; Shi X; Jiang BH
    Am J Physiol Cell Physiol; 2004 Aug; 287(2):C281-91. PubMed ID: 15028555
    [TBL] [Abstract][Full Text] [Related]  

  • 8. c-Myc regulates cyclin D-Cdk4 and -Cdk6 activity but affects cell cycle progression at multiple independent points.
    Mateyak MK; Obaya AJ; Sedivy JM
    Mol Cell Biol; 1999 Jul; 19(7):4672-83. PubMed ID: 10373516
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Herceptin-induced inhibition of phosphatidylinositol-3 kinase and Akt Is required for antibody-mediated effects on p27, cyclin D1, and antitumor action.
    Yakes FM; Chinratanalab W; Ritter CA; King W; Seelig S; Arteaga CL
    Cancer Res; 2002 Jul; 62(14):4132-41. PubMed ID: 12124352
    [TBL] [Abstract][Full Text] [Related]  

  • 10. YC-1-inhibited proliferation of rat mesangial cells through suppression of cyclin D1-independent of cGMP pathway and partially reversed by p38 MAPK inhibitor.
    Chiang WC; Teng CM; Lin SL; Chen YM; Tsai TJ; Hsieh BS
    Eur J Pharmacol; 2005 Jul; 517(1-2):1-10. PubMed ID: 15950964
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of the tuberous sclerosis complex-2 tumor suppressor gene product tuberin as a target of the phosphoinositide 3-kinase/akt pathway.
    Manning BD; Tee AR; Logsdon MN; Blenis J; Cantley LC
    Mol Cell; 2002 Jul; 10(1):151-62. PubMed ID: 12150915
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PTEN induces cell cycle arrest by decreasing the level and nuclear localization of cyclin D1.
    Radu A; Neubauer V; Akagi T; Hanafusa H; Georgescu MM
    Mol Cell Biol; 2003 Sep; 23(17):6139-49. PubMed ID: 12917336
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BCR/ABL regulates expression of the cyclin-dependent kinase inhibitor p27Kip1 through the phosphatidylinositol 3-Kinase/AKT pathway.
    Gesbert F; Sellers WR; Signoretti S; Loda M; Griffin JD
    J Biol Chem; 2000 Dec; 275(50):39223-30. PubMed ID: 11010972
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phosphatidylinositol 3-kinase/Akt pathway regulates tuberous sclerosis tumor suppressor complex by phosphorylation of tuberin.
    Dan HC; Sun M; Yang L; Feldman RI; Sui XM; Ou CC; Nellist M; Yeung RS; Halley DJ; Nicosia SV; Pledger WJ; Cheng JQ
    J Biol Chem; 2002 Sep; 277(38):35364-70. PubMed ID: 12167664
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phosphatidylinositol 3-kinase couples the interleukin-2 receptor to the cell cycle regulator E2F.
    Brennan P; Babbage JW; Burgering BM; Groner B; Reif K; Cantrell DA
    Immunity; 1997 Nov; 7(5):679-89. PubMed ID: 9390691
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FTY720 induces apoptosis of human hepatoma cell lines through PI3-K-mediated Akt dephosphorylation.
    Lee TK; Man K; Ho JW; Sun CK; Ng KT; Wang XH; Wong YC; Ng IO; Xu R; Fan ST
    Carcinogenesis; 2004 Dec; 25(12):2397-405. PubMed ID: 15297371
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Molecular mechanisms controlling the cell cycle: fundamental aspects and implications for oncology].
    Viallard JF; Lacombe F; Belloc F; Pellegrin JL; Reiffers J
    Cancer Radiother; 2001 Apr; 5(2):109-29. PubMed ID: 11355576
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of Akt/protein kinase B overcomes a G(2)/m cell cycle checkpoint induced by DNA damage.
    Kandel ES; Skeen J; Majewski N; Di Cristofano A; Pandolfi PP; Feliciano CS; Gartel A; Hay N
    Mol Cell Biol; 2002 Nov; 22(22):7831-41. PubMed ID: 12391152
    [TBL] [Abstract][Full Text] [Related]  

  • 19. c-Myc or cyclin D1 mimics estrogen effects on cyclin E-Cdk2 activation and cell cycle reentry.
    Prall OW; Rogan EM; Musgrove EA; Watts CK; Sutherland RL
    Mol Cell Biol; 1998 Aug; 18(8):4499-508. PubMed ID: 9671459
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanosensitive p27Kip1 regulation and cell cycle entry in vascular smooth muscle cells.
    Sedding DG; Seay U; Fink L; Heil M; Kummer W; Tillmanns H; Braun-Dullaeus RC
    Circulation; 2003 Aug; 108(5):616-22. PubMed ID: 12835226
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.